IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures - Top-Institutions - MDSpire

IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures

  • By

  • Luigi Angrisani

  • Antonella Santonicola

  • Paola Iovino

  • Rossella Palma

  • Lilian Kow

  • Gerhard Prager

  • Almino Ramos

  • Scott Shikora

  • March 4, 2024

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Surgery
    • Obesity Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Surgery
    • Endocrinology

  • #3

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Surgery
    • Surgical Research

  • #4

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Research
    • Public Health

  • #5

    University of São Paulo Medical School
    University of São Paulo Medical School

    São Paulo, São Paulo

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Surgery
    • Clinical Research

Original Source(s)

IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures

  • by Luigi Angrisani, Antonella Santonicola, Paola Iovino, Rossella Palma, Lilian Kow, Gerhard Prager, Almino Ramos, Scott Shikora

  • March 4, 2024

Related Content

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

Management of Recurrent Weight Gain After Sleeve Gastrectomy: Comparative Effectiveness of Conversion Procedures Versus Obesity Management Medications

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.